Scarica l'app Stockscreener
2.225
0.00%
0.005
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MRVI Giù?
Forum
Previsione
Maravai Lifesciences Holdings Inc Borsa (MRVI) Ultime notizie
MRVI: TriLink BioTechnologies Partners with Quantoom for Enhanced mRNA Production | MRVI Stock News - GuruFocus
TriLink and Quantoom partner to expand global vaccine access - Investing.com Australia
Maravai's TriLink, Quantoom Sign License, Supply Agreement - marketscreener.com
TriLink and Quantoom partner to expand global vaccine access By Investing.com - Investing.com UK
Leading COVID-19 Vaccine Technology CleanCap Expands Global Access Through Quantoom Partnership - Stock Titan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Stock Holdings Cut by Bank of America Corp DE - Defense World
ProShare Advisors LLC Raises Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Maravai LifeSciences Announces Shareholder Meeting Results - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences Sees Unusually Large Options Volume (NASDAQ:MRVI) - Defense World
Maravai Lifesciences Holds Annual Shareholders Meeting - TipRanks
Maravai LifeSciences Announces Shareholder Meeting Results By Investing.com - Investing.com Canada
BNP Paribas Financial Markets Purchases Shares of 66,443 Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Bronstein, Gewirtz & Grossman, LLC Encourages Maravai LifeSciences Holdings, Inc. (MRVI) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
CORRECTION -- Maravai LifeSciences Releases 2024 Sustainability Report | MRVI Stock News - GuruFocus
Maravai LifeSciences Releases 2024 Sustainability Report Highlighting Product Innovation, Governance Enhancements, and Commitment to Sustainable Growth - Nasdaq
CORRECTIONMaravai LifeSciences Releases 2024 Sustainability Report - The Manila Times
CORRECTION – Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire
Maravai Sustainability Report: 10x Manufacturing Expansion Plus Major Green Energy Milestones - Stock Titan
Maravai LifeSciences Releases 2024 Sustainability Report - GlobeNewswire
Maravai LifeSciencesReleases 2024 Sustainability Report - The Manila Times
Maravai LifeSciences Sustainability Report: 49 New Products and 10X GMP Manufacturing Expansion Drive Growth - Stock Titan
Northern Trust Corp Buys 53,474 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Revolutionary mRNA Synthesis Kit Achieves 2X Yield, 85% Lower dsRNA: TriLink's Game-Changing Launch - Stock Titan
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Given Consensus Recommendation of “Hold” by Brokerages - Defense World
Maravai LifeSciences Q1 2025 Earnings Call: Growth Amid Challenges - TipRanks
Price T Rowe Associates Inc. MD Acquires 7,946 Shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Robert W. Baird Has Lowered Expectations for Maravai LifeSciences (NASDAQ:MRVI) Stock Price - Defense World
Stock Traders Buy Large Volume of Put Options on Maravai LifeSciences (NASDAQ:MRVI) - Defense World
TriLink BioTechnologies® and the International Vaccine Institute Sign a Memorandum of Understanding to Support the Development of mRNA-based Vaccines - marketscreener.com
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q1 Loss, Tops Revenue Estimates - MSN
RBC Capital Sticks to Their Buy Rating for Maravai Lifesciences Holdings (MRVI) - The Globe and Mail
Major mRNA Vaccine Breakthrough: TriLink and IVI Join Forces to Transform Global Vaccine Access - Stock Titan
Maravai (MRVI) Offers 2025 Revenue Outlook Excluding Key Factors - GuruFocus
MRVI: Analyst Firm Lowers Price Target for Maravai LifeSciences - GuruFocus
These Analysts Slash Their Forecasts On Maravai LifeSciences Following Q1 Results - Benzinga
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Maravai LifeSciences (MRVI) Exceeds Q1 Revenue Expectations | MR - GuruFocus
Maravai (MRVI) Offers 2025 Revenue Outlook Excluding Key Factors | MRVI Stock News - GuruFocus
Maravai Lifesciences (MRVI) Price Target Reduced by Baird Analys - GuruFocus
Assessing Maravai LifeSciences: Insights From 5 Financial Analysts - Benzinga
Maravai LifeSciences (MRVI) Target Price Lowered by Baird | MRVI Stock News - GuruFocus
MRVI: Analyst Reduces Price Target but Maintains Buy Rating on M - GuruFocus
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q1 2025 Earnings Call Transcript - Insider Monkey
Maravai Lifesciences (MRVI) Price Target Reduced by Baird Analyst | MRVI Stock News - GuruFocus
Maravai LifeSciences Holdings Inc (MRVI) Q1 2025 Earnings Call Highlights: Navigating Growth ... - Yahoo Finance
Maravai LifeSciences Holdings Inc (MRVI) Q1 2025 Earnings Call H - GuruFocus
Maravai LifeSciences Holdings, Inc. 2025 Q1ResultsEarnings Call Presentation (NASDAQ:MRVI) - Seeking Alpha
Earnings call transcript: Maravai Lifesciences Q1 2025 sees revenue beat, stock up - Investing.com
Maravai LifeSciences Q1 Adjusted Loss Widens, Revenue Falls - marketscreener.com
Maravai LifeSciences Q1 2025 Earnings: Revenue Beats Estimates a - GuruFocus
Maravai LifeSciences (MRVI) Exceeds Q1 Revenue Expectations | MRVI Stock News - GuruFocus
Maravai Lifesciences Reports First Quarter 2025 Financial Results | MRVI Stock News - GuruFocus
Maravai Lifesciences Reports First Quarter 2025 Financial Results - The Manila Times
Dimensional Fund Advisors LP Grows Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) - Defense World
Class Action Filed Against Maravai LifeSciences Holdings, Inc. (MRVI)May 5, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire
0.87%
0.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):